14- 118 C.M.R. ch. 11, § 8 - Confidentiality
1. Pursuant to
22
MRSA §7250(1),
prescription monitoring information is confidential and not a public record as
defined in Title 1, section 402, subsection
3. Breaches of the confidentiality may
result in criminal prosecution and/or administrative sanctions.
2. Pursuant to
22
MRSA §7250(3), the
Office may provide de-identified copies of prescription monitoring information
to researchers who have signed written agreements restricting the use of the
data for research, policy, or educational purposes. The Office may make
aggregate information based on prescription monitoring information available to
the public.
3. The Office shall
periodically conduct an audit review of the Monitor for compliance with the
terms of the contract regarding confidentiality of information concerning the
prescription drug, prescriber, pharmacy, patient and dispenser.
4. The Monitor shall fully cooperate with the
Office in any audit review conducted pursuant to Subsection 3.
5. The Office and the Monitor shall purge
from the database all prescription monitoring information that is older than
six (6) years old.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.